Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Vicarious Surgical Inc.

Get SEC filing alerts via email and in your feed for Vicarious Surgical Inc.

RBOT RBOT-WT

Vicarious Surgical Inc.

About Vicarious Surgical Inc.

Vicarious Surgical designs and develops advanced robotic systems for minimally invasive surgery, focusing on single-port platforms that enhance dexterity, visualization, and ease of use. Its proprietary technology aims to improve patient outcomes, reduce costs, and expand access to complex procedures. Targeting global markets, the company seeks regulatory approval to commercialize innovative, human-like surgical robots for various abdominal and gynecological surgeries.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Vicarious Surgical Inc.

1
1
Vicarious Surgical Inc. Vicarious Surgical Reports $7.3 Million Net Loss, Shifts to OTCQB Market

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Vicarious Surgical Inc. Vicarious Surgical Faces Financial Challenges and Delisting from NYSE

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Vicarious Surgical Inc. Vicarious Surgical Reports Q3 2025 Financial Results with Reduced Losses and Ongoing Development of Surgical Robot

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Vicarious Surgical Inc. Vicarious Surgical Reports $13.2 Million Net Loss in Q2 2025, Focuses on Funding and Development

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Vicarious Surgical Inc. Vicarious Surgical Reports $15.4 Million Net Loss in Q1 2025, Faces Financial Challenges

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Vicarious Surgical Inc. Vicarious Surgical Reports $63.2 Million Net Loss for Fiscal Year 2024, Seeks FDA Approval for Surgical System

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Vicarious Surgical Inc. Vicarious Surgical Reports Financial Changes, Net Loss Improvement in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments